Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence

Author(s): Nur-Vaizura Mohamad, Soelaiman Ima-Nirwana, Kok-Yong Chin*

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 20 , Issue 9 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Osteoporosis is one of the major health issues associated with menopause-related estrogen deficiency. Various reports suggest that the hormonal changes related to menopausal transition may lead to the derangement of redox homeostasis and ultimately oxidative stress. Estrogen deficiency and oxidative stress may enhance the expression of genes involved in inflammation. All these factors may contribute, in synergy, to the development of postmenopausal osteoporosis. Previous studies suggest that estrogen may act as an antioxidant to protect the bone against oxidative stress, and as an antiinflammatory agent in suppressing pro-inflammatory and pro-osteoclastic cytokines. Thus, the focus of the current review is to examine the relationship between estrogen deficiency, oxidative stress and inflammation, and the impacts of these phenomena on skeletal health in postmenopausal women.

Keywords: Inflammation, menopause, estrogen, osteoporosis, oxidative stress, review.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [1478 - 1487]
Pages: 10
DOI: 10.2174/1871530320666200604160614

Article Metrics

PDF: 26